Table 2. Studies utilized to characterize Shigella CHIM endpoints and to develop a disease severity score.

Reference	PI	N	Dose (cfu)
NCT00485134	Harro	22	800
Antimicrob Agents and Chemother. 2008;52(3). [33]	Taylor	15	1500
Infect Immun. 1999; 67(7) [29]	Coster	7	2000
Clin Infec Dis 2006; 42(9) [26]	Taylor	10	1500